BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8132804)

  • 21. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.
    Blanks RG; Moss SM; Coleman DA; Swerdlow AJ
    BJOG; 2007 Nov; 114(11):1408-13. PubMed ID: 17803716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
    Lynge E; Poll P
    IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing the national invasive cervical cancer audit: a local perspective.
    Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
    BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative cytology preceding cervical cancer: causes and prevention.
    Robertson JH; Woodend B
    J Clin Pathol; 1993 Aug; 46(8):700-2. PubMed ID: 8408692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical screening in women over the age of 50: results of a population-based multicentre study.
    Flannelly G; Monaghan J; Cruickshank M; Duncan I; Johnson J; Jordan J; Campbell M; Patnick J
    BJOG; 2004 Apr; 111(4):362-8. PubMed ID: 15008774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical smear histories of Maori women developing invasive cervical cancer.
    Ratima K; Paul C; Skegg DC
    N Z Med J; 1993 Dec; 106(969):519-21. PubMed ID: 8183492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False negative rate in cervical cytology.
    van der Graaf Y; Vooijs GP
    J Clin Pathol; 1987 Apr; 40(4):438-42. PubMed ID: 3584488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristics of false negative cervical smears--implications for the UK cervical cancer screening programme.
    Baker RW; O'Sullivan JP; Hanley J; Coleman DV
    J Clin Pathol; 1999 May; 52(5):358-62. PubMed ID: 10560356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health authority cervical screening recall policies and time since last smear: a retrospective cohort analysis in the north west England.
    Howe A; Owen-Smith V; Richardson J
    J Med Screen; 2003; 10(4):184-8. PubMed ID: 14746327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting uptake of cervical and breast cancer screening among perimenopausal women in Hong Kong.
    Chan C; Ho SC; Chan SG; Yip YB; Wong FC; Cheng F
    Hong Kong Med J; 2002 Oct; 8(5):334-41. PubMed ID: 12376710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of population coverage in cervical cancer screening in the Oxford region.
    Coulter A; Baldwin A
    J R Coll Gen Pract; 1987 Oct; 37(303):441-3. PubMed ID: 3505283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the effect of introducing a restrictive cervical screening policy on laboratory workload and cervical cancer detection rates.
    Channer JL; Mackenzie EF
    Cytopathology; 1990; 1(1):13-7. PubMed ID: 2130995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.